Core Viewpoint - The company reported a significant increase in revenue and net profit for the first half of 2025, driven by a recovery in the pesticide industry and strategic adjustments in its operations [5][6]. Financial Performance - The company achieved operating revenue of 2.08 billion yuan, a year-on-year increase of 7.28% [5]. - The net profit attributable to shareholders reached 42.28 million yuan, reflecting a substantial year-on-year growth of 117.75% [5]. - As of June 30, 2025, total assets amounted to 971.42 million yuan, up 12.42% from the beginning of the year, while net assets attributable to shareholders increased by 0.58% to 425.30 million yuan [5]. Market Dynamics - The pesticide industry experienced a rebound in market demand, leading to intensified competition [5]. - The company actively engaged in international markets, achieving export sales of 1.09 billion yuan, which is a 19.61% increase compared to the previous period [6]. Strategic Initiatives - The company is focusing on optimizing its product structure and enhancing production efficiency through cost reduction measures, including process optimization and technological upgrades [6]. - A significant project involves relocating and upgrading production facilities along the Yangtze River, which has effectively released production capacity [6]. Investment Project Changes - The company plans to change part of its fundraising investment projects, shifting from a project for producing 3,500 tons of glyphosate to two new projects: one for producing 1,000 tons of prothioconazole and another for 4,200 tons of pyrethroid series products [36][39]. - The decision to change the investment projects is based on current market conditions and aims to enhance the efficiency of fund utilization and optimize the company's product portfolio [45][46]. Governance Changes - The company has proposed to cancel its supervisory board and amend its articles of association to streamline governance and improve management efficiency [51][52]. - This change will transfer the supervisory responsibilities to the audit committee of the board, pending approval from the shareholders' meeting [51][52].

Core Viewpoint - The company reported a significant increase in revenue and net profit for the first half of 2025, driven by a rebound in the pesticide market and strategic initiatives to enhance competitiveness and optimize product structure [8]. Financial Performance - The company achieved operating revenue of 2,082.97 million yuan, representing a year-on-year growth of 7.28% [8]. - The net profit attributable to shareholders reached 42.28 million yuan, marking a substantial increase of 117.75% compared to the previous year [8]. - As of June 30, 2025, total assets amounted to 9,714.20 million yuan, up 12.42% from the beginning of the year, while net assets attributable to shareholders increased by 0.58% to 4,252.98 million yuan [8]. Market and Operational Insights - The international pesticide market demand has rebounded, prompting the company to actively engage with overseas clients and optimize its product offerings [8]. - Export sales reached 1,086.84 million yuan, reflecting a year-on-year growth of 19.61% [8]. - The company is focusing on production adjustments and cost reduction through process optimization and management upgrades to enhance market competitiveness [8]. Corporate Governance Changes - The company plans to cancel its supervisory board and amend its articles of association to streamline governance and improve management efficiency [36][37]. - The decision to eliminate the supervisory board will be submitted for approval at the upcoming shareholders' meeting [36][37].

股票代码：002391 股票简称：长青股份 公告编号：2025-020 江苏长青农化股份有限公司 第九届监事会第三次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载，误导性陈述或重大遗漏。 江苏长青农化股份有限公司（以下简称"公司"）第九届监事会第三次会议 于 2025 年 8 月 7 日在公司会议室以现场方式召开，会议通知于 2025 年 7 月 22 日以通讯方式发送至公司全体监事。会议由监事会主席于国庆先生主持，会议应 到监事 3 人，实到监事 3 人。本次会议的召集、召开程序及出席会议的监事人数 符合《公司法》和《公司章程》的规定。 经与会监事认真审议，本次会议以记名投票表决方式通过了以下决议： 一、审议通过了《2025 年半年度报告及其摘要》 经审核，监事会认为：董事会编制和审核公司《2025 年半年度报告及其摘 要》的程序符合法律、行政法规和中国证监会的规定，报告内容真实、准确、完 整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或重大遗漏。 《2025 年半年度报告》刊登于 2025 年 8 月 11 日的巨潮资讯网； 《2025 年半 年度报告摘要 ...

民生证券股份有限公司 关于江苏长青农化股份有限公司变更部分募集资金投资项目的 核查意见 民生证券股份有限公司（以下简称"民生证券"或"保荐机构"）作为江苏长青 农化股份有限公司（以下简称"长青股份"或"公司"）持续督导的保荐机构，民生 证券根据《证券发行上市保荐业务管理办法》 《深圳证券交易所上市规则》 《上市 公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》、 《深圳证券 交易所上市公司自律监管指引第 13 号——保荐业务》、《深圳证券交易所上市公 司自律监管指引第 1 号——主板上市公司规范运作》等相关法律法规的规定和要 求，通过定期的现场检查、资料查阅、沟通访谈及列席重要会议等方式，对长青 股份变更部分募集资金投资项目事项进行了核查，具体情况如下： 一、募集资金的基本情况 经中国证券监督管理委员会《关于核准江苏长青农化股份有限公司公开发行 （证监许可[2018]2097 号）核准，公司于 2019 年 2 月 27 可转换公司债券的批复》 日向社会公开发行 913.8 万张可转换公司债券，每张面值 100 元，公开发行可转 债 募 集 资 金 总 额 为 913,800,000.00 元 ...